Clinical Trials Directory

Trials / Unknown

UnknownNCT05012137

The MEV of 0.5% Ropivacaine in Ultrasound-guided SASIS-FICB

The Minimum Effective Volume (MEV) of 0.5% Ropivacaine in Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Aim of This Study is to Determine the Minimum Effective Volume of Local Anesthetic (Ropivacaine 0.5%) Required to Produce an Effective Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block(SASIS-FICB) for Surgical Anesthesia in 90% of Patients Scheduled for Elective Surgery of One Lower Limbs.

Detailed description

The study is based on biased coin design, and the volume of Local Anesthetic (Ropivacaine 0.5%) for the next patient is determined by the result of the last one. In the case of block failure, the volume will be increased by 2.5ml. Conversely, block success will result in either a reduction in volume by 2.5ml (probability 11%) or no change in volume (probability 89%). A blinded assistant will assess sensory and motor blockade in each nerve territory ( the femoral, obturator and lateral femoral cutaneous nerves) at 5-min intervals up to 30 min after completion of the block. Finally, MEV90 is calculated by isotonic regression.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) with 0.5% ropivacaineall the patients received Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)
DRUGdifferent volume of 0.5% ropivacaineAccording to the subject's response to the injection dose, the next subject will be injected with a different volume of the drug according to the preset rules

Timeline

Start date
2021-08-25
Primary completion
2021-10-25
Completion
2021-11-25
First posted
2021-08-19
Last updated
2021-08-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05012137. Inclusion in this directory is not an endorsement.